The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.
The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'
Obiettivo: comprendere le risposte a breve e lungo termine dei servizi antidroga a un importante flusso di sfollati e le relative sfide.
Contesto: la COVID-19 ha sollevato l'attenzione in Europa e nel mondo sull'importanza di monitorare la preparazione a potenziali emergenze.